FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2139540775> ?p ?o ?g. }

• W2139540775 endingPage "1247" @default.
• W2139540775 startingPage "1240" @default.
• W2139540775 abstract "Methotrexate (MTX) and mercaptopurine (MP) are widely used antileukemic agents that inhibit de novo purine synthesis (DNPS) as a mechanism of their antileukemic effects. To elucidate pharmacodynamic differences among children with acute lymphoblastic leukemia (ALL), DNPS was measured in leukemic blasts from newly diagnosed patients before and after therapy with these agents. Patients were randomized to receive low-dose MTX (LDMTX: 6 oral doses of 30 mg/m2) or high-dose MTX (HDMTX: intravenous 1 g/m2) followed by intravenous MP; or intravenous MP alone (1 g/m2), as initial therapy. At diagnosis, the rate of DNPS in bone marrow leukemia cells was 3-fold higher in patients with T-lineage ALL compared with those with B-lineage ALL (769 ± 189 vs 250 ± 38 fmol/nmol/h;P = .001). DNPS was not consistently inhibited following MP alone but was markedly inhibited following MTX plus MP (median decrease 3% vs 94%; P &lt; .001). LDMTX plus MP and HDMTX plus MP produced greater antileukemic effects (percentage decrease in circulating leukocyte counts) compared with MP alone (−50% ± 4%, −56% ± 3%, and − 20% ± 4%, respectively;P &lt; .0001). Full DNPS inhibition was associated with greater antileukemic effects compared with partial or no inhibition (−63% ± 4% vs −37% ± 4%; P &lt; .0001) in patients with nonhyperdiploid B-lineage and T-lineage ALL. HDMTX plus MP yielded 2-fold higher MTX polyglutamate concentrations than LDMTX plus MP (2148 ± 298 vs 1075 ± 114 pmol/109 cells;P &lt; .01) and a higher percentage of patients with full DNPS inhibition (78% vs 53%; P &lt; .001). Thus, the extent of DNPS inhibition was related to in vivo antileukemic effects, and a single dose of intravenous MP produced minimal DNPS inhibition and antileukemic effects, whereas MTX plus MP produced greater antileukemic effects and DNPS inhibition, with full inhibition more frequent after HDMTX." @default.
• W2139540775 created "2016-06-24" @default.
• W2139540775 creator A5009866488 @default.
• W2139540775 creator A5010643609 @default.
• W2139540775 creator A5013818931 @default.
• W2139540775 creator A5018363328 @default.
• W2139540775 creator A5024937927 @default.
• W2139540775 creator A5030075618 @default.
• W2139540775 creator A5034189317 @default.
• W2139540775 creator A5044548428 @default.
• W2139540775 creator A5073369495 @default.
• W2139540775 creator A5073701026 @default.
• W2139540775 creator A5076645797 @default.
• W2139540775 creator A5086250633 @default.
• W2139540775 date "2002-08-15" @default.
• W2139540775 modified "2023-10-16" @default.
• W2139540775 title "De novo purine synthesis inhibition and antileukemic effects of mercaptopurine alone or in combination with methotrexate in vivo" @default.
• W2139540775 cites W1520363931 @default.
• W2139540775 cites W1597766366 @default.
• W2139540775 cites W1908994222 @default.
• W2139540775 cites W1964969943 @default.
• W2139540775 cites W1978971015 @default.
• W2139540775 cites W1988055549 @default.
• W2139540775 cites W1988838355 @default.
• W2139540775 cites W200461798 @default.
• W2139540775 cites W2047861739 @default.
• W2139540775 cites W2058471639 @default.
• W2139540775 cites W2058917512 @default.
• W2139540775 cites W2065550112 @default.
• W2139540775 cites W2071406318 @default.
• W2139540775 cites W2077771104 @default.
• W2139540775 cites W2080061212 @default.
• W2139540775 cites W2083020021 @default.
• W2139540775 cites W2095694615 @default.
• W2139540775 cites W2105288217 @default.
• W2139540775 cites W2134190122 @default.
• W2139540775 cites W2147996630 @default.
• W2139540775 cites W2155080284 @default.
• W2139540775 cites W2168633685 @default.
• W2139540775 cites W2410765131 @default.
• W2139540775 cites W4232761037 @default.
• W2139540775 cites W4242108431 @default.
• W2139540775 doi "https://doi.org/10.1182/blood-2002-02-0495" @default.
• W2139540775 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12149204" @default.
• W2139540775 hasPublicationYear "2002" @default.
• W2139540775 type Work @default.
• W2139540775 sameAs 2139540775 @default.
• W2139540775 citedByCount "87" @default.
• W2139540775 countsByYear W21395407752012 @default.
• W2139540775 countsByYear W21395407752013 @default.
• W2139540775 countsByYear W21395407752014 @default.
• W2139540775 countsByYear W21395407752016 @default.
• W2139540775 countsByYear W21395407752017 @default.
• W2139540775 countsByYear W21395407752018 @default.
• W2139540775 countsByYear W21395407752019 @default.
• W2139540775 countsByYear W21395407752020 @default.
• W2139540775 countsByYear W21395407752021 @default.
• W2139540775 countsByYear W21395407752022 @default.
• W2139540775 countsByYear W21395407752023 @default.
• W2139540775 crossrefType "journal-article" @default.
• W2139540775 hasAuthorship W2139540775A5009866488 @default.
• W2139540775 hasAuthorship W2139540775A5010643609 @default.
• W2139540775 hasAuthorship W2139540775A5013818931 @default.
• W2139540775 hasAuthorship W2139540775A5018363328 @default.
• W2139540775 hasAuthorship W2139540775A5024937927 @default.
• W2139540775 hasAuthorship W2139540775A5030075618 @default.
• W2139540775 hasAuthorship W2139540775A5034189317 @default.
• W2139540775 hasAuthorship W2139540775A5044548428 @default.
• W2139540775 hasAuthorship W2139540775A5073369495 @default.
• W2139540775 hasAuthorship W2139540775A5073701026 @default.
• W2139540775 hasAuthorship W2139540775A5076645797 @default.
• W2139540775 hasAuthorship W2139540775A5086250633 @default.
• W2139540775 hasBestOaLocation W21395407751 @default.
• W2139540775 hasConcept C109246011 @default.
• W2139540775 hasConcept C126322002 @default.
• W2139540775 hasConcept C150903083 @default.
• W2139540775 hasConcept C181199279 @default.
• W2139540775 hasConcept C185592680 @default.
• W2139540775 hasConcept C207001950 @default.
• W2139540775 hasConcept C2776476023 @default.
• W2139540775 hasConcept C2776694085 @default.
• W2139540775 hasConcept C2776863199 @default.
• W2139540775 hasConcept C2777173762 @default.
• W2139540775 hasConcept C2778397455 @default.
• W2139540775 hasConcept C2778461978 @default.
• W2139540775 hasConcept C2780007613 @default.
• W2139540775 hasConcept C2781059491 @default.
• W2139540775 hasConcept C2781107101 @default.
• W2139540775 hasConcept C2781382166 @default.
• W2139540775 hasConcept C2909962599 @default.
• W2139540775 hasConcept C55493867 @default.
• W2139540775 hasConcept C71924100 @default.
• W2139540775 hasConcept C86803240 @default.
• W2139540775 hasConcept C98274493 @default.
• W2139540775 hasConceptScore W2139540775C109246011 @default.
• W2139540775 hasConceptScore W2139540775C126322002 @default.
• W2139540775 hasConceptScore W2139540775C150903083 @default.
• W2139540775 hasConceptScore W2139540775C181199279 @default.

• next